Growth Metrics

TherapeuticsMD (TXMD) Gross Profit: 2010-2023

Historic Gross Profit for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2023 value amounting to $1.3 million.

  • TherapeuticsMD's Gross Profit fell 99.27% to $502,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year decrease of 98.89%. This contributed to the annual value of $1.3 million for FY2023, which is 98.10% down from last year.
  • TherapeuticsMD's Gross Profit amounted to $1.3 million in FY2023, which was down 98.10% from $68.6 million recorded in FY2022.
  • TherapeuticsMD's 5-year Gross Profit high stood at $68.6 million for FY2022, and its period low was $1.2 million during FY2021.
  • Over the past 3 years, TherapeuticsMD's median Gross Profit value was $1.3 million (recorded in 2023), while the average stood at $23.7 million.
  • Per our database at Business Quant, TherapeuticsMD's Gross Profit skyrocketed by 5,755.34% in 2022 and then plummeted by 98.10% in 2023.
  • TherapeuticsMD's Gross Profit (Yearly) stood at $43.3 million in 2019, then climbed by 12.89% to $48.9 million in 2020, then plummeted by 97.61% to $1.2 million in 2021, then soared by 5,755.34% to $68.6 million in 2022, then slumped by 98.10% to $1.3 million in 2023.